EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential targeting of human pyroptotic caspase-5 and caspase-4 by Shigella OspC2 and OspC3

Kyungsub Kim iD, Marcos Antonio Valdespino Diaz iD, Rowan M Karr iD, Michele E Muscolo iD, Lisa Goers iD, Truelian Yu, Tera C Levin iD, Jonathan N Pruneda iD, Cammie F Lesser iD

mBio · 11.03.2026 · 17 (3)

DOI: 10.1128/mbio.03855-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, erschienen am 11.03.2026. Verfasst von Kyungsub Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Caspases, Initiator, Caspases, Pyroptosis, Host-Pathogen Interactions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis is an inflammatory cell death pathway that is a key defense mechanism of intestinal epithelial cells. To successfully establish an infection, intracytosolic gram-negative pathogens must block this host response. Indeed, a Shigella effector OspC3, injected into cells by its type III secretion system, suppresses epithelial pyroptosis by targeting and inactivating caspase-4 (CASP4). Here, we demonstrate that OspC2, which shares 96% identity with OspC3, targets caspase-5 (CASP5), a close paralog of CASP4. Through a combination of yeast two-hybrid, transfection, and bacterial infection assays, we show that the distinct pyroptotic caspase specificities of OspC2 and OspC3 are determined by a short α-helical region, designated the pyroptotic caspase specificity (PCS) domain. This domain is located upstream from the ankyrin-rich repeat (ARR) region previously established to promote OspC3 binding to CASP4. Swapping PCS domains between OspC2 and OspC3 is sufficient to redirect their caspase targeting. Evidence for CASP5-driven pyroptosis in response to infection has not yet been established. However, CASP5 displays signatures of positive selection at residues predicted to interact with the PCS domain of OspC2. Notably, the introduction of orangutan-specific residues into human CASP5 disrupts its interaction with and modification by OspC2, demonstrating that CASP5 natural variation can cause key functional differences in this host-microbe molecular interaction. These findings highlight the evolutionary interplay between bacterial effectors and host proteins, support a likely role for CASP5 in responding to gram-negative bacteria, and identify promising therapeutic targets for enhancing epithelial defense against bacterial pathogens. IMPORTANCE Shigella species are human-specific gram-negative pathogens that establish a replicative niche in intestinal epithelial cells by blocking pyroptosis, a key inflammatory cell death pathway. We reveal that two closely related Shigella type III secreted effectors, OspC2 and OspC3, specifically inactivate the human caspase paralogs CASP5 and CASP4, respectively. This specificity is determined by their newly identified pyroptotic caspase specificity (PCS) domains. In addition, we find that positively selected residues in CASP5 alter the OspC2/CASP5 interaction, underscoring the impacts of ongoing evolutionary arms races between bacterial effectors and host immune proteins. By elucidating the molecular basis of caspase targeting and adaptation, this work provides new insight into the diversification of host defense mechanisms and identifies potential therapeutic targets for enhancing epithelial resistance to bacterial infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Caspases, InitiatorCaspasesPyroptosisHost-Pathogen InteractionsShigellaBacterial ProteinsHumansEpithelial CellsProtein BindingTwo-Hybrid System Techniques

Stichwörter der Autor:innen

CASP5OspC2Shigellaeffectorpyroptotic caspase specificityt3SS

Substanzen

CASP4 protein, humanCaspases, InitiatorCASP5 protein, humanCaspasesBacterial Proteins

Autor:innen und Institutionen

  • Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, USA.
  • Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, Oregon, USA.
  • Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.

ORCID-Profile: Kyungsub Kim, Marcos Antonio Valdespino Diaz, Rowan M Karr, Michele E Muscolo, Lisa Goers, Tera C Levin, Jonathan N Pruneda, Cammie F Lesser

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Kim, K., Valdespino Diaz, M. A., Karr, R. M., Muscolo, M. E., Goers, L., Yu, T., Levin, T. C., Pruneda, J. N., & Lesser, C. F. (2026). Differential targeting of human pyroptotic caspase-5 and caspase-4 by Shigella OspC2 and OspC3. mBio, 17(3). https://doi.org/10.1128/mbio.03855-25

Vancouver

Kim K, Valdespino Diaz MA, Karr RM, Muscolo ME, Goers L, Yu T, et al. Differential targeting of human pyroptotic caspase-5 and caspase-4 by Shigella OspC2 and OspC3. mBio. 2026;17(3). doi:10.1128/mbio.03855-25

BibTeX
@article{Kim2026,
  author = {Kim, Kyungsub and Valdespino Diaz, Marcos Antonio and Karr, Rowan M and Muscolo, Michele E and Goers, Lisa and Yu, Truelian and Levin, Tera C and Pruneda, Jonathan N and Lesser, Cammie F},
  title = {Differential targeting of human pyroptotic caspase-5 and caspase-4 by Shigella OspC2 and OspC3},
  journal = {mBio},
  year = {2026},
  volume = {17},
  number = {3},
  doi = {10.1128/mbio.03855-25}
}
Kostenlos starten →